Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The Saccharomyces cerevisiae Sir2 protein is an NAD(+)-dependent histone deacetylase that plays a critical role in transcriptional silencing, genome stability, and longevity. A human homologue of Sir2, SIRT1, regulates the activity of the p53 tumor suppressor and inhibits apoptosis. The Sir2 deacetylation reaction generates two products: O-acetyl-ADP-ribose and nicotinamide, a precursor of nicotinic acid and a form of niacin/vitamin B(3). We show here that nicotinamide strongly inhibits yeast silencing, increases rDNA recombination, and shortens replicative life span to that of a sir2 mutant. Nicotinamide abolishes silencing and leads to an eventual delocalization of Sir2 even in G(1)-arrested cells, demonstrating that silent heterochromatin requires continual Sir2 activity. We show that physiological concentrations of nicotinamide noncompetitively inhibit both Sir2 and SIRT1 in vitro. The degree of inhibition by nicotinamide (IC(50) < 50 microm) is equal to or better than the most effective known synthetic inhibitors of this class of proteins. We propose a model whereby nicotinamide inhibits deacetylation by binding to a conserved pocket adjacent to NAD(+), thereby blocking NAD(+) hydrolysis. We discuss the possibility that nicotinamide is a physiologically relevant regulator of Sir2 enzymes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although NAM has been shown to be effective to increase NAD+ in tissues, it also exerts an inhibitory effect on sirtuin [88] and PARPs activity [89].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [88]
In the citing paper
“Deacetylation of PGC-1α is required to sequester it in the nucleus and this cellular redistribution is prevented by nicotinamide, a potent SIRT1 inhibitor [64].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [64]
Citations
Cites
Genomic Expression Programs in the Response of Yeast Cells to Environmental Changes
Gasch, A. P., Spellman, P. T., Kao, C. M., Carmel-Harel, O., Eisen, M. B., Storz, G., Botstein, D., & Brown, P. O. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4241 · Cited by 4,815
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Lin, S.-J., Defossez, P.-A., & Guarente, L. (2000) · Science · doi:10.1126/science.289.5487.2126 · Cited by 1,775
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Extrachromosomal rDNA circles—a cause of aging in yeast
Sinclair, D. A., & Guarente, L. (1997) · Cell · doi:10.1016/s0092-8674(00)80493-6 · Cited by 1,500
Self-citationPosition effect at S. cerevisiae telomeres: Reversible repression of Pol II transcription
Gottschling, D. E., Aparicio, O. M., Billington, B. L., & Zakian, V. A. (1990) · Cell · doi:10.1016/0092-8674(90)90141-z · Cited by 1,345
Research works printed but not linked: 1
- Gasser, 1998, Novartis Found. Symp., 214, 114
Cited by
Items 101–200 of 1,000
Nicotinamide-induced Mitophagy
Jang, S.-Y., Kang, H. T., & Hwang, E. S. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.363747 · Cited by 262
“However, SIRT1 activity is also inhibited by NAM itself (35), which makes it difficult to directly point to SIRT1 as a key mediator of the effect of NAM.”
BackgroundNicotinamide N -Methyltransferase: More Than a Vitamin B3 Clearance Enzyme
Pissios, P. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2017.02.004 · Cited by 259
“Both sirtuins and PARPs break NAD and release NAM, which inhibits their enzymatic activity [34,35].”
Liu, D., Gharavi, R., Pitta, M., Gleichmann, M., & Mattson, M. P. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8058-1 · Cited by 249
“The function of several enzymes that play important roles in the cellular responses to stress require NAD+ for their activity including NAD+-dependent class III histone deacetylases (HDAC) particularly sirtuin 1 (SIRT1) (Blander and Guarente 2004).”
BackgroundStructural basis for sirtuin function: What we know and what we don't
Sanders, B. D., Jackson, B., & Marmorstein, R. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.009 · Cited by 244
Sirtinol promotes PEPCK1 degradation and inhibits gluconeogenesis by inhibiting deacetylase SIRT2
Zhang, M., Pan, Y., Dorfman, R. G., Yin, Y., Zhou, Q., Huang, S., Liu, J., & Zhao, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-00035-9 · Cited by 250
Cross‐Talk between Aging and Cancer: The Epigenetic Language
FRAGA, M. F., AGRELO, R., & ESTELLER, M. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1395.005 · Cited by 251
Wang, B., Hasan, M. K., Alvarado, E., Yuan, H., Wu, H., & Chen, W. Y. (2011) · Oncogene · doi:10.1038/onc.2010.468 · Cited by 245
Mitochondrial protein acetylation regulates metabolism
Anderson, K. A., & Hirschey, M. D. (2012) · Essays in Biochemistry · doi:10.1042/bse0520023 · Cited by 249
“The dependence of the sirtuins on NAD+ suggests that their enzymatic activity is directly linked to the energy status of the cell, either via the cellular NAD+/NADH ratio, the absolute levels of NAD+, NADH or NAM, or a combination of these variables [18–22].”
BackgroundDai, Y., Rahmani, M., Dent, P., & Grant, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5429-5444.2005 · Cited by 245
“Acetylation is reciprocally regulated by histone acetyltransferases (HATs) and HDACs (40).”
BackgroundInfluentialSIRT1-Mediated eNAMPT Secretion from Adipose Tissue Regulates Hypothalamic NAD+ and Function in Mice
Yoon, M. J., Yoshida, M., Johnson, S., Takikawa, A., Usui, I., Tobe, K., Nakagawa, T., Yoshino, J., & Imai, S.-I. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.002 · Cited by 243
“SIRT1 Regulates eNAMPT Secretion by Physically Interacting with and Deacetylating iNAMPT SIRT1 enzymatic activity is effectively inhibited by nicotinamide in culture conditions (Bitterman et al., 2002).”
Cellular Senescence: Molecular Mechanisms, In Vivo Significance, and Redox Considerations
Muller, M. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2104 · Cited by 238
“Whereas SIRT1 is NAD (cid:5) dependent, the by-product of deacetylation, nicotinamide, is a noncompetitive inhibitor of Sir2 and SIRT1, acting as a negative regulator (32).”
Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression
Yang, X.-J., & Seto, E. (2003) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(03)00015-7 · Cited by 241
Exercise Training Promotes SIRT1 Activity in Aged Rats
Ferrara, N., Rinaldi, B., Corbi, G., Conti, V., Stiuso, P., Boccuti, S., Rengo, G., Rossi, F., & Filippelli, A. (2008) · Rejuvenation Research · doi:10.1089/rej.2007.0576 · Cited by 238
The Vitamin Nicotinamide: Translating Nutrition into Clinical Care
Maiese, K., Chong, Z. Z., Hou, J., & Shang, Y. C. (2009) · Molecules · doi:10.3390/molecules14093446 · Cited by 234
“Physiological concentrations of nicotinamide noncompetitively inhibit Sir2, suggesting that nicotinamide is a physiologically relevant regulator of Sir2 enzymes [338].”
BackgroundIncreased Mutagenesis and Unique Mutation Signature Associated with Mitotic Gene Conversion
Hicks, W. M., Kim, M., & Haber, J. E. (2010) · Science · doi:10.1126/science.1191125 · Cited by 232
Mechanism of Nicotinamide Inhibition and Transglycosidation by Sir2 Histone/Protein Deacetylases
Jackson, M. D., Schmidt, M. T., Oppenheimer, N. J., & Denu, J. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306552200 · Cited by 239
Bitterman, K. J., Medvedik, O., & Sinclair, D. A. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.3.376-399.2003 · Cited by 234
“from the unique Sir2 reaction may initiate a signal transduction pathway or may themselves allow for regulated control of the enzyme (16, 143).”
BackgroundInfluentialSelf-citationSirtuin regulation in aging and injury
Poulose, N., & Raju, R. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.08.017 · Cited by 236
“NAM is a potent inhibitor of sirtuinmediated deacetylation [32].”
BackgroundMicroReview: Small molecules that regulate lifespan: evidence for xenohormesis
Lamming, D. W., Wood, J. G., & Sinclair, D. A. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04209.x · Cited by 232
“Nicotinamide and its analogues such as N-methyl nicotinamide are effective inhibitors of sirtuin activity and may be valuable in a clinical setting (Bitterman et al., 2002; Anderson et al., 2003a).”
Self-citationMicrobial NAD Metabolism: Lessons from Comparative Genomics
Gazzaniga, F., Stebbins, R., Chang, S. Z., McPeek, M. A., & Brenner, C. (2009) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00042-08 · Cited by 230
“Additionally, because NAD-consuming enzymes such as sirtuins are inhibited by nicotinamide (10), there may be a selection for evolution or acquisition of enzymes performing nicotinamide salvage.”
BackgroundNicotinamide Riboside—The Current State of Research and Therapeutic Uses
Mehmel, M., Jovanović, N., & Spitz, U. (2020) · Nutrients · doi:10.3390/nu12061616 · Cited by 221
“On the contrary, NAM does not affect lipid blood levels, yet it can exhibit sirtuin-inhibiting effects at higher doses [116,149].”
BackgroundHST2 Mediates SIR2 -Independent Life-Span Extension by Calorie Restriction
Lamming, D. W., Latorre-Esteves, M., Medvedik, O., Wong, S. N., Tsang, F. A., Wang, C., Lin, S.-J., & Sinclair, D. A. (2005) · Science · doi:10.1126/science.1113611 · Cited by 226
Self-citationSmith, Jr., McClure, J. M., Matecic, M., & Smith, J. S. (2007) · Aging Cell · doi:10.1111/j.1474-9726.2007.00326.x · Cited by 218
“NAM is a noncompetitive inhibitor of Sir2p and the other yeast Sirtuins (Hst1p, Hst2p, Hst3p and Hst4p), and has been shown to shorten RLS when added to the growth media at a concentration of 5 mM (Landry et al., 2000a; Bitterman et al., 2002).”
BackgroundYang, H., Zhou, L., Shi, Q., Zhao, Y., Lin, H., Zhang, M., Zhao, S., Yang, Y., Ling, Z., Guan, K., et al. (2015) · The EMBO Journal · doi:10.15252/embj.201591041 · Cited by 222
“We found that GOT2 was indeed acetylated and its acetylation was enhanced by approximately 2.5-fold after 4 h of treatment with nicotinamide (NAM), an inhibitor of the SIRT family deacetylases (Bitterman et al, 2002; Avalos et al, 2005) (Fig 1B).”
BackgroundInfluentialHan, B., Li, S., Lv, Y., Yang, D., Li, J., Yang, Q., Wu, P., Lv, Z., & Zhang, Z. (2019) · Food & Function · doi:10.1039/c9fo01152h · Cited by 226
Acetyl-coenzyme A synthetase (AMP forming)
Starai, V. J., & Escalante-Semerena, J. C. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-3448-x · Cited by 214
Miyazaki, R., Ichiki, T., Hashimoto, T., Inanaga, K., Imayama, I., Sadoshima, J., & Sunagawa, K. (2008) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.166991 · Cited by 214
Role of NAD+ and mitochondrial sirtuins in cardiac and renal diseases
Hershberger, K. A., Martin, A. S., & Hirschey, M. D. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.5 · Cited by 218
Oxidative Damage to Specific Proteins in Replicative and Chronological-aged Saccharomyces cerevisiae
Reverter-Branchat, G., Cabiscol, E., Tamarit, J., & Ros, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404849200 · Cited by 218
Stimulation of muscle cell glucose uptake by resveratrol through sirtuins and AMPK
Breen, D. M., Sanli, T., Giacca, A., & Tsiani, E. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.06.104 · Cited by 213
Borra, M. T., Langer, M. R., Slama, J. T., & Denu, J. M. (2004) · Biochemistry · doi:10.1021/bi049592e · Cited by 214
“We (27) and others ( 37 ) have also shown that nicotinamide is a noncompetitive inhibitor (versus NAD+) with ySir2 and human SIRT1, suggesting that these enzymes FIGURE 7: Rates of nicotinamide and OAADPR formation.”
BackgroundInvolvement of mammalian sirtuin 1 in the action of ethanol in the liver
You, M., Liang, X., Ajmo, J. M., & Ness, G. C. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00575.2007 · Cited by 214
Histone deacetylase inhibitors as therapeutics for polyglutamine disorders
Butler, R., & Bates, G. P. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1989 · Cited by 214
“The nicotinamide product is a non-competitive inhibitor of sirtuin”
Sauve, A. A., & Schramm, V. L. (2003) · Biochemistry · doi:10.1021/bi034959l · Cited by 215
Protective effects and mechanisms of sirtuins in the nervous system
Zhang, F., Wang, S., Gan, L., Vosler, P. S., Gao, Y., Zigmond, M. J., & Chen, J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.09.001 · Cited by 211
Conze, D., Brenner, C., & Kruger, C. L. (2019) · Scientific Reports · doi:10.1038/s41598-019-46120-z · Cited by 210
SIRT1 regulation of apoptosis of human chondrocytes
Takayama, K., Ishida, K., Matsushita, T., Fujita, N., Hayashi, S., Sasaki, K., Tei, K., Kubo, S., Matsumoto, T., Fujioka, H., et al. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24864 · Cited by 206
“To examine the functions of SIRT1 in human chondrocytes, we used sirtinol and nicotinamide, known as inhibitors of SIRT1 in various cell sources (30,31).”
BackgroundMethodNewman, J. C., He, W., & Verdin, E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.404863 · Cited by 207
An overview of Sirtuins as potential therapeutic target: Structure, function and modulators
Wang, Y., He, J., Liao, M., Hu, M., Li, W., Ouyang, H., Wang, X., Ye, T., Zhang, Y., & Ouyang, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.10.028 · Cited by 202
Linking chromatin function with metabolic networks: Sir2 family of NAD+-dependent deacetylases
Denu, J. M. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(02)00005-1 · Cited by 208
“yeast silencing, increases rDNA recombination and shortens replicative lifespan to that of a Sir2 mutant [ 63 ].”
BackgroundInfluentialNAD and the aging process: role in life, death and everything in between
Chini, C. C. S., Tarragó, M. G., & Chini, E. N. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.11.003 · Cited by 208
Histone Deacetylase 1-Mediated Histone Modification Regulates Osteoblast Differentiation
Lee, H. W., Suh, J. H., Kim, A. Y., Lee, Y. S., Park, S. Y., & Kim, J. B. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0061 · Cited by 205
Hara, N., Yamada, K., Shibata, T., Osago, H., Hashimoto, T., & Tsuchiya, M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610357200 · Cited by 205
Peled, T., Shoham, H., Aschengrau, D., Yackoubov, D., Frei, G., Rosenheimer G, N., Lerrer, B., Cohen, H. Y., Nagler, A., Fibach, E., et al. (2012) · Experimental Hematology · doi:10.1016/j.exphem.2011.12.005 · Cited by 197
“In lower eukaryotes, Sir2 (the mammalian SIRT1 homolog) has been strongly implicated in the modulation of replicative life span and promotion of longevity in response to stress, while NAM strongly inhibits silencing and shortens replicative life span [13].”
BackgroundInfluentialSelf-citationLi, F.-L., Liu, J.-P., Bao, R.-X., Yan, G., Feng, X., Xu, Y.-P., Sun, Y.-P., Yan, W., Ling, Z.-Q., Xiong, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-02950-5 · Cited by 196
Berretta, J., Pinskaya, M., & Morillon, A. (2008) · Genes & Development · doi:10.1101/gad.458008 · Cited by 190
Ageing and the border between health and disease
MacNee, W., Rabinovich, R. A., & Choudhury, G. (2014) · European Respiratory Journal · doi:10.1183/09031936.00134014 · Cited by 189
Janke, R., Dodson, A. E., & Rine, J. (2015) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-100814-125544 · Cited by 191
“Nicotinamide is reported to be a noncompetitive inhibitor of Sir2 and human SIRT1 (Avalos et al. 2005, Bitterman et al. 2002).”
BackgroundTrapp, J., Meier, R., Hongwiset, D., Kassack, M. U., Sippl, W., & Jung, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200700003 · Cited by 193
Jeninga, E. H., Schoonjans, K., & Auwerx, J. (2010) · Oncogene · doi:10.1038/onc.2010.206 · Cited by 193
“This could occur, either by an increase in NADþ levels, which activates Sirt1, or by a decrease in the levels of NAM, which act as a potent inhibitor of Sirt1 (Bitterman et al., 2002; Anderson et al., 2003).”
BackgroundMammalian Sirtuins and Energy Metabolism
Li, X., & Kazgan, N. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.575 · Cited by 192
“The activity of these enzymes is also inhibited by their common enzymatic product, nicotinamide (19), and possibly by NADH (20).”
BackgroundHentchel, K. L., & Escalante-Semerena, J. C. (2015) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00020-15 · Cited by 191
Nicotinamide Clearance by Pnc1 Directly Regulates Sir2-Mediated Silencing and Longevity
Gallo, C. M., Smith, D. L., & Smith, J. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.3.1301-1312.2004 · Cited by 193
“NAM has been shown to inhibit the deacetylase activity of several Sir2 family members, including yeast Sir2 and Hst2 (5, 35) and the human versions SIRT1, SIRT2, and SIRT3 (41, 48, 56).”
BackgroundResultInfluentialIncreased Life Span due to Calorie Restriction in Respiratory-Deficient Yeast
Kaeberlein, M., Hu, D., Kerr, E. O., Tsuchiya, M., Westman, E. A., Dang, N., Fields, S., & Kennedy, B. K. (2005) · PLoS Genetics · doi:10.1371/journal.pgen.0010069 · Cited by 189
“CR has also been proposed to activate Sir2 by reducing cellular pools of nicotinamide, a Sir2 inhibitor [50].”
Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead
Mai, A., & Altucci, L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.08.020 · Cited by 191
Escande, C., Chini, C. C. S., Nin, V., Dykhouse, K. M., Novak, C. M., Levine, J., van Deursen, J., Gores, G. J., Chen, J., Lou, Z., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39319 · Cited by 183
Zhang, X., Ji, R., Liao, X., Castillero, E., Kennel, P. J., Brunjes, D. L., Franz, M., Möbius-Winkler, S., Drosatos, K., George, I., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.030486 · Cited by 186
Zhao, K., Harshaw, R., Chai, X., & Marmorstein, R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401057101 · Cited by 187
Longevity, lipotoxicity and leptin: the adipocyte defense against feasting and famine
Unger, R. H. (2005) · Biochimie · doi:10.1016/j.biochi.2004.11.014 · Cited by 184
“The mechanisms by which caloric restriction seems to extend longevity have not been fully elucidated, but interacting genetic and metabolic factors seem likely to be involved [1,3–8].”
BackgroundEapen, V. V., Sugawara, N., Tsabar, M., Wu, W.-H., & Haber, J. E. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00566-12 · Cited by 169
“The presence of a cleavable HO cutting site within HMR was confirmed by adding the SIR2 inhibitor nicotinamide to desilence HMR (4) prior to inducing HO (Fig.”
BackgroundChristensen, D. G., Xie, X., Basisty, N., Byrnes, J., McSweeney, S., Schilling, B., & Wolfe, A. J. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01604 · Cited by 181
The role of NAD+ metabolism and its modulation of mitochondria in aging and disease
Yusri, K., Jose, S., Vermeulen, K. S., Tan, T. C. M., & Sorrentino, V. (2025) · npj Metabolic Health and Disease · doi:10.1038/s44324-025-00067-0 · Cited by 219
“For example, NAM caninhibit the activity of human sirtuin 1 (SIRT1) and PARPs in vitro 55,56 .”
Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells
Hwang, E. S., & Song, S. B. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2527-8 · Cited by 174
Hong, W., Mo, F., Zhang, Z., Huang, M., & Wei, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00246 · Cited by 174
SIRT3 regulates mitochondrial protein acetylation and intermediary metabolism
Hirschey, M. D., Shimazu, T., Huang, J. Y., Schwer, B., & Verdin, E. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010850 · Cited by 180
“The dependence of sirtuins on NADþ suggests that their enzymatic activity is directly linked to the energy status of the cell via the cellular NADþ:NADH ratio; the absolute levels of NADþ, NADH, or nicotinamide; or a combination of these variables (Lin et al. 2000, 2002, 2004; Bitterman et al. 2002; Anderson et al. 20…”
BackgroundPfister, J. A., Ma, C., Morrison, B. E., & D'Mello, S. R. (2008) · PLoS ONE · doi:10.1371/journal.pone.0004090 · Cited by 178
“. In these paradigms therefore, the effect of SIRT1 is mediated by its enzymatic activity. To examine whether this was also the case in CGNs, we examined whether nicotinamide could block the protective effect of SIRT1 against LK-induced neuronal death. Nicotinamide is an end-product inhibitor that suppresses the activ…”
BackgroundLife Span Extension and Neuronal Cell Protection by Drosophila Nicotinamidase
Balan, V., Miller, G. S., Kaplun, L., Balan, K., Chong, Z.-Z., Li, F., Kaplun, A., VanBerkum, M. F. A., Arking, R., Freeman, D. C., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804681200 · Cited by 176
Zhang, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706644200 · Cited by 170
Audrito, V., Vaisitti, T., Rossi, D., Gottardi, D., D'Arena, G., Laurenti, L., Gaidano, G., Malavasi, F., & Deaglio, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4452 · Cited by 168
“SIRT1 functions are inhibited by nicotinamide in CLL cells We then asked whether nicotinamide, the main precursor of NADþ and a noncompetitive inhibitor of SIRT1 (30, 31), is active in leukemic cells.”
BackgroundPorcu, M., & Chiarugi, A. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.12.009 · Cited by 173
NAD metabolism and sirtuins: Metabolic regulation of protein deacetylation in stress and toxicity
Yang, T., & Sauve, A. A. (2006) · The AAPS Journal · doi:10.1208/aapsj080472 · Cited by 169
Genes determining yeast replicative life span in a long-lived genetic background
Kaeberlein, M., Kirkland, K. T., Fields, S., & Kennedy, B. K. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2004.10.007 · Cited by 171
“4 18 Bitterman et al. (2002) SP1-1 22.”
miR-181a increases FoxO1 acetylation and promotes granulosa cell apoptosis via SIRT1 downregulation
Zhang, M., Zhang, Q., Hu, Y., Xu, L., Jiang, Y., Zhang, C., Ding, L., Jiang, R., Sun, J., Sun, H., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.467 · Cited by 167
“induced by nicotinamide (NAM), which blocks SIRT1 activity in KGN cells.(27) Contrarily, trichostatin A (TSA), an inhibitor of class I and II histone deacetylases (HDACs), had no obvious”
BackgroundA therapeutic role for sirtuins in diseases of aging?
WESTPHAL, C., DIPP, M., & GUARENTE, L. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.09.008 · Cited by 168
Structural Basis for Sirtuin Activity and Inhibition
Yuan, H., & Marmorstein, R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.372300 · Cited by 160
“The nicotinamide product is also a noncompetitive inhibitor of sirtuins (10) and inhibits the enzyme through a base-exchange process by reacting with a catalytic intermediate to reform -NAD at the expense of deacetylation (11, 12).”
BackgroundZhang, D., Hu, X., Li, J., Liu, J., Baks-te Bulte, L., Wiersma, M., Malik, N.-U.-A., van Marion, D. M. S., Tolouee, M., Hoogstra-Berends, F., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09014-2 · Cited by 162
Sauve, A. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.01.021 · Cited by 161
“inhibited [26,63], and Ki values are in the 200 μM range or below for a number of these enzymes.”
Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer
Jung-Hynes, B., Nihal, M., Zhong, W., & Ahmad, N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807869200 · Cited by 165
The role of insulin and IGF-1 signaling in longevity
Katic, M., & Kahn, C. R. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4297-y · Cited by 159
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
“Deacetylation of PGC-1α is required to sequester it in the nucleus and this cellular redistribution is prevented by nicotinamide, a potent SIRT1 inhibitor [64].”
Self-citationHung, C., Chan, S., Chu, P., & Tsai, K. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500144 · Cited by 172
“SIRT1 plays an important role in regulating the pathogenesis of chronic conditions such as diabetes, neurodegenerative diseases, chronic inflammatory pulmonary diseases, and other cardiovascular diseases [14].”
BackgroundMechanisms underlying the transcriptional regulation of skeletal myogenesis
Sartorelli, V., & Caretti, G. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2005.04.015 · Cited by 193
FOXOs and Sirtuins in Vascular Growth, Maintenance, and Aging
Oellerich, M. F., & Potente, M. (2012) · Circulation Research · doi:10.1161/circresaha.111.246488 · Cited by 157
Easlon, E., Tsang, F., Skinner, C., Wang, C., & Lin, S.-J. (2008) · Genes & Development · doi:10.1101/gad.1648308 · Cited by 161
“It has been suggested that moderate CR induces Sir2dependent life span extension by decreasing the level of nictotinamide (NAM), a byproduct of NAD degradation in the Sir2-mediated deacetylation reaction (Bitterman et al. 2002).”
BackgroundRajendrasozhan, S., Yang, S.-R., Edirisinghe, I., Yao, H., Adenuga, D., & Rahman, I. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1938 · Cited by 159
“The deacetylating activity of sirtuins depends on NAD+ and is inhibited by the reaction product, nicotinamide (IC50 <50 μM) (6).”
Mai, A., Valente, S., Meade, S., Carafa, V., Tardugno, M., Nebbioso, A., Galmozzi, A., Mitro, N., De Fabiani, E., Altucci, L., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm9008289 · Cited by 156
Bai, L., Pang, W.-J., Yang, Y.-J., & Yang, G.-S. (2007) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-007-9592-5 · Cited by 160
“Nicotinamide, a form of vitamin B3 [42] and a product of sirtuin catalyzed deacetylation, is a strong noncompetitive inhibitor of yeast Sir2 and human Sirt1 activity, both in vitro and in vivo [43].”
Jin, L., Galonek, H., Israelian, K., Choy, W., Morrison, M., Xia, Y., Wang, X., Xu, Y., Yang, Y., Smith, J. J., et al. (2009) · Protein Science · doi:10.1002/pro.50 · Cited by 151
Self-citationYu, J., & Auwerx, J. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2009.12.006 · Cited by 154
“In fact, NAD+ is indispensible to the deacetylase activity of the Sir2 family proteins whereas the reaction by-product NAM blunts their activities [70-72].”
BackgroundLibri, V., Yandım, C., Athanasopoulos, S., Loyse, N., Natisvili, T., Law, P. P., Chan, P. K., Mohammad, T., Mauri, M., Tam, K. T., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60382-2 · Cited by 180
Sirtuin 1 (SIRT1): The Misunderstood HDAC
Stünkel, W., & Campbell, R. M. (2011) · SLAS DISCOVERY · doi:10.1177/1087057111422103 · Cited by 164
A human tRNA synthetase is a potent PARP1-activating effector target for resveratrol
Sajish, M., & Schimmel, P. (2015) · Nature · doi:10.1038/nature14028 · Cited by 151
“g, Only the full-length TyrRS (1-528) and none of the various fragments of TyrRS (mini-TyrRS (1-364), ΔN-TyrRS (228-528) or the C-domain (328-528)) interacts with PARP-1.”
BackgroundStructural Basis for the Mechanism and Regulation of Sir2 Enzymes
Avalos, J. L., Boeke, J. D., & Wolberger, C. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00082-6 · Cited by 170
Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.11.005 · Cited by 149
“Physiological concentrations of nicotinamide noncompetitively inhibit both Sir2 and SIRT1 in vitro, suggesting that nicotinamide is a physiologically relevant regulator of Sir2 enzymes [22].”
BackgroundSIRT1: Regulator of p53 Deacetylation
Lee, J. T., & Gu, W. J. (2013) · Genes & Cancer · doi:10.1177/1947601913484496 · Cited by 163
Senawong, T., Peterson, V. J., Avram, D., Shepherd, D. M., Frye, R. A., Minucci, S., & Leid, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307477200 · Cited by 146
Coenzyme Specificity of Sir2 Protein Deacetylases
Schmidt, M. T., Smith, B. C., Jackson, M. D., & Denu, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407484200 · Cited by 147
Administration of nicotinamide riboside prevents oxidative stress and organ injury in sepsis
Hong, G., Zheng, D., Zhang, L., Ni, R., Wang, G., Fan, G.-C., Lu, Z., & Peng, T. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.05.073 · Cited by 147
“However, the use of niacin is limited by painful flushing [48], and nicotinamide may inhibit SIRTs [49], a family of de-acetylases required for various essentially cellular functions.”
The Nuts and Bolts of Transcriptionally Silent Chromatin in Saccharomyces cerevisiae
Gartenberg, M. R., & Smith, J. S. (2016) · Genetics · doi:10.1534/genetics.112.145243 · Cited by 162
“Sir2 is strongly inhibited by NAM in vitro (IC50 50 mM), and in vivo by the addition of NAM to the growth medium (Bitterman et al. 2002).”
BackgroundBiological and Potential Therapeutic Roles of Sirtuin Deacetylases
Taylor, D. M., Maxwell, M. M., Luthi‐Carter, R., & Kazantsev, A. G. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8357-y · Cited by 159
Metadata
- Authors
- Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Sinclair, David A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 47
- Pages
- 45099-45107
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2167990179
- Cited by
- 1,002
- References
- 66
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 33 · 2022: 36 · 2021: 41 · 2020: 38 · 2019: 39 · 2018: 47 · 2017: 43 · 2016: 43 · 2015: 58 · 2014: 40 · 2013: 58 · 2012: 56
- FWCI
- 21.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6554 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG11972-01)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- nicotinamide, Sir2, SIRT1, transcriptional silencing, heterochromatin, replicative lifespan, aging, NAD+ hydrolysis, enzyme inhibition, p53, apoptosis, histone deacetylation
- MeSH terms
- Aging, DNA, Ribosomal, Genes, Fungal, Histone Deacetylases, Humans, Life Expectancy, Luminescent Proteins, Models, Biological, Niacinamide, Recombinant Fusion Proteins, Recombination, Genetic, Saccharomyces cerevisiae, Molecular Structure, Telomere, Gene Silencing, Sirtuins, Silent Information Regulator Proteins, Saccharomyces cerevisiae, Green Fluorescent Proteins, Sirtuin 1, Sirtuin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.